$31.60
+1.25 (+4.12%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-27.94%
1Y
+60.24%
YTD
-35.01%
Open$30.90
Previous Close$30.35
Day High$32.46
Day Low$30.62
52W High$56.05
52W Low$19.07
Volume—
Avg Volume1.65M
Market Cap2.37B
P/E Ratio—
EPS$-5.54
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$46.91
Below
SMA 200
$30.68
Above
RSI (14)
41.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+199.4% upside
Current
$31.60
$31.60
Target
$94.61
$94.61
$72.50
$94.61 avg
$144.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 672.08M | 640.49M | 736.20M |
| Net Income | -5,512,106 | -4,610,660 | -5,991,019 |
| Profit Margin | -0.8% | -0.7% | -0.8% |
| EBITDA | -7,633,568 | -6,751,763 | -9,172,286 |
| Free Cash Flow | -4,482,853 | -2,925,974 | -4,789,156 |
| Rev Growth | +20.0% | +11.6% | +0.9% |
| Debt/Equity | 0.79 | 0.70 | 0.90 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |